title: Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy.
authors: Nephrology and Transplantation Unit, Rizk Hospital, Beirut, Lebanon. lird@cyberia.net.lb
authors: A
authors: A
authors: Barbari
authors: A
authors: A
authors: Stephan
authors: M
authors: M
authors: Masri
authors: N
authors: N
authors: Mourad
authors: G
authors: G
authors: Kamel
authors: H
authors: H
authors: Kilani
authors: A
authors: A
authors: Karam
authors: I A
authors: IA
authors: Daya
mesh_terms: D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine